#focusoncovalentdrugs — Public Fediverse posts

#FocusOnCovalentDrugs was a great meeting with talks covering diverse aspects of targeted covalent inhibitor discovery ranging from warhead development and #chemoproteomics to very advanced PK/PD topics. Thank you so much to the organizers for inviting me and to everyone for the fruitful discussions.

Fanboy moment for me today at #FocusOnCovalentDrugs. Hearing Matthias Gehringer present for the first time. His reviews on covalent warheads are a must-read in my group for many years now.

#Chemistry #ChemBio #DrugDiscovery #covalent

https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01153
https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01825

Fanboy moment for me today at #FocusOnCovalentDrugs. Hearing Matthias Gehringer present for the first time. His reviews on covalent warheads are a must-read in my group for many years now.

#Chemistry #ChemBio #DrugDiscovery #covalent

https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01153
https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01825

Fanboy moment for me today at #FocusOnCovalentDrugs. Hearing Matthias Gehringer present for the first time. His reviews on covalent warheads are a must-read in my group for many years now.

#Chemistry #ChemBio #DrugDiscovery #covalent

https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01153
https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c01825

Amazing talk by Sebastian Essig at #FocusOnCovalentDrugs. He talked about covalent drug discovery with a focus on characterizing novel warheads. Great insights into library design, reactivity profiling and #chemoproteomics for global analysis of selectivity.

#FocusOnCovalentDrugs is off to a great start with an inspiring talk by Marcus Bantscheff. He talked about the various #chemoproteomics technologies that his group is applying to better understand the targets of small molecule drugs. Interesting insights into #ABPP and #TPP. (1/2)
#Chemistry #ChemBio